Australian biotech market today 28.04.09
Tuesday, 28 April, 2009
The healthcare indices are up a very healthy 2.6 per cent on the market at 3.00pm on a day when other shares lost yesterday’s gains.
Biota (ASX:BTA) is down a touch following its massive rise yesterday, when shares shot up 80 per cent. It has settled at a very respectable $1.50 today.
Investors obviously like the look of any stocks with a whiff of swine flu, as vaccine developer CSL (ASX:CLS) is up $1.15 to $33.
In terms of the other majors, Cochlear (ASX:COH) is up $1 while ResMed (ASX:RMD) is up 3c.
Hexima (ASX:HXL) is up 3c to 45c – see our profile of the agbiotech company, published today.
Alchemia (ASX:ACL) is almost 19 per cent, while Mesoblast (ASX:MSB) is down 4c to 73c.
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
